-
Azithromycin: From Ribosome Mechanism to PK/PD Strategy
2026-08-15
A translational framework for using Azithromycin in bacterial infection research, resistance profiling, PK/PD study design, and carefully bounded trypanosomosis models.
-
Calnexin and CFTR Variant Rescue by Correctors
2026-08-15
Tedman et al. map how the ER chaperone calnexin shapes CFTR expression and corrector responsiveness across 232 clinical variants. Their deep mutational scanning framework separates mutation-driven drug selectivity from proteostasis-dependent rescue, offering a basis for more predictive genotype-to-theratype studies in cystic fibrosis research.
-
In Vitro Drug Response: Arrest Versus Death
2026-08-14
Hannah R. Schwartz’s doctoral dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for separating proliferative arrest from cell killing, improving how researchers interpret compound screens and design follow-up experiments.
-
Pregnancy, LNP Structure, and mRNA Delivery Outcomes
2026-08-14
The reference study demonstrates that lipid nanoparticle structure and administration route jointly determine mRNA expression, inflammatory signaling, and maternal–fetal outcomes during pregnancy. Its mechanistic findings provide a framework for separating delivery potency from immunogenicity when adapting mRNA workflows to mammalian cell and translational research.
-
Tobramycin for Reproducible Cell Assays
2026-08-13
This scenario-driven guide explains how Tobramycin, SKU B1856, can be incorporated into bacterial perturbation, co-culture, and antibiotic resistance workflows without confusing antimicrobial activity with host-cell cytotoxicity. It covers aqueous formulation, controls, concentration design, data interpretation, and practical product-selection criteria.
-
Protease Inhibitor Cocktail for Lysate Stability
2026-08-13
The Protease Inhibitor Cocktail is a water-soluble 100X mixture for reducing proteolytic and chelation-sensitive degradation during cell and tissue extraction. Its EDTA component can protect against metalloprotease activity but may interfere with metal-dependent assays, so downstream compatibility requires validation.
-
Ceramides Promote Fish Nodavirus Replication via Autophagy
2026-08-12
A recent Journal of Virology study uses global lipidomics and targeted perturbation experiments to identify ceramide accumulation as a pro-viral feature of red-spotted grouper nervous necrosis virus infection. The work connects three ceramide synthesis routes to autophagy-dependent viral replication, providing a mechanistic framework for studying lipid metabolism in aquatic virology.
-
Annexin V Binding: A Decision Framework
2026-08-12
Learn how Annexin V, a calcium-dependent phosphatidylserine binding protein, reports membrane-state changes without being mistaken for a standalone death verdict. This guide connects molecular mechanism, reagent quality, assay design, and translational interpretation.
-
Calpain Inhibitor I, ALLN: Protocol Guide
2026-08-11
Calpain Inhibitor I, ALLN (SKU A2602) provides experimental control of calpain I/II and cathepsin B/L activity in protease-focused apoptosis, inflammation, and ischemia-reperfusion workflows. It is for scientific research only, not diagnostic or therapeutic use, and its water insolubility requires controlled DMSO preparation, vehicle-matched controls, and careful storage.
-
Prednisolone for Glucocorticoid Signaling Research
2026-08-10
Prednisolone is a practical synthetic glucocorticoid for dissecting receptor-driven inflammation, immune regulation, and cellular response to corticosteroids. Used as a mechanistic comparator alongside ERAD-engaging degradation studies, it helps separate transcriptional immunomodulation from direct loss of transmembrane proteins such as PD-L1.
-
Everolimus (RAD001): Readouts That Matter
2026-08-09
Everolimus (RAD001) is a powerful mTOR pathway probe, but its biological effect should not be inferred from a single viability measurement. This guide connects mTOR signaling, time-resolved assay design, and apoptosis interpretation to improve cancer research decisions.
-
Prochlorperazine: Assay Workflows for Translational Research
2026-08-08
Prochlorperazine connects established antiemetic therapy with practical melanoma research workflows, including dose-response, migration, and MITF–tyrosinase assays. This guide translates its receptor profile and the acute mountain sickness prevention protocol into actionable setup, optimization, and troubleshooting decisions for cancer research laboratories.
-
α2-Adrenergic Modulation of Equine Airway Contraction
2026-08-07
This study distinguished presynaptic from postsynaptic effects of α2-adrenergic stimulation in isolated equine distal airways. Clonidine and xylazine suppressed nerve-evoked, but not exogenous acetylcholine-evoked, contraction, while Tolazoline prevented the inhibition, supporting a mechanism involving reduced cholinergic neurotransmitter release.
-
Sunitinib in RCC Research: Mechanisms, Resistance, and Solut
2026-08-07
This article explores the mechanistic foundation and translational applications of Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, in renal cell carcinoma (RCC) research. By blending recent evidence on combination strategies—specifically, chrysin-induced ferroptosis to overcome resistance—with actionable protocol guidance and competitive positioning, it provides a strategic roadmap for translational investigators seeking to optimize experimental design and impact.
-
Applied Protocols with Recombinant Human IL-15 in Immune Cel
2026-08-06
Leverage Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) to unlock robust T cell and NK cell activation in advanced immunology and neuroimmune workflows. Explore precision protocol guidance, troubleshooting strategies, and the unique cross-domain advantages enabled by APExBIO’s high-purity recombinant cytokine.
454 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page